Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous
Status:
Unknown status
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether trimethoprim/sulfamethoxazole is effective
in preventing serious infectious complications (those that require hospitalization or lead to
death) in patients with lupus erythematosus that receive intermediate or high dose steroids.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Collaborator:
National Council of Science and Technology, Mexico
Treatments:
Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination